A citation-based method for searching scientific literature

Shuo Wang, Anna Prizment, Bharat Thyagarajan, Anne Blaes. Cancers (Basel) 2021
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine.
Daniel D Von Hoff, Thomas Ervin, Francis P Arena, E Gabriela Chiorean, Jeffrey Infante, Malcolm Moore, Thomas Seay, Sergei A Tjulandin, Wen Wee Ma, Mansoor N Saleh,[...]. N Engl J Med 2013
50

CA 19-9 in pancreatic cancer: retrospective evaluation of patients with suspicion of pancreatic cancer.
Victor Molina, Laura Visa, Carles Conill, Salvador Navarro, Jose M Escudero, Jose M Auge, Xavier Filella, Miguel A Lopez-Boado, Joana Ferrer, Laureano Fernandez-Cruz,[...]. Tumour Biol 2012
29
50

Mixture and non-mixture cure fraction models based on the generalized modified Weibull distribution with an application to gastric cancer data.
Edson Z Martinez, Jorge A Achcar, Alexandre A A Jácome, José S Santos. Comput Methods Programs Biomed 2013
18
50

Sarcopenia is an independent predictor of delayed gastric emptying following pancreaticoduodenectomy: a retrospective study.
Ryuta Shintakuya, Masaru Sasaki, Atsushi Nakamitsu, Mohei Kohyama, Tatsuya Tazaki, Yoichi Sugiyama, Toshinori Hirano, Yuki Kaiki. ANZ J Surg 2019
2
50

Pancreas Adenocarcinoma: Ascites, Clinical Manifestations, and Management Implications.
Angel Mier Hicks, Joanne Chou, Marinela Capanu, Maeve A Lowery, Kenneth H Yu, Eileen M O'Reilly. Clin Colorectal Cancer 2016
16
50

Outcomes of adult-to-adult living donor liver transplantation: a single institution's experience with 335 consecutive cases.
Daisuke Morioka, Hiroto Egawa, Mureo Kasahara, Takashi Ito, Hironori Haga, Yasutsugu Takada, Hiroshi Shimada, Koichi Tanaka. Ann Surg 2007
145
50

Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma.
Naoto Fujiwara, Hayato Nakagawa, Yotaro Kudo, Ryosuke Tateishi, Masataka Taguri, Takeyuki Watadani, Ryo Nakagomi, Mayuko Kondo, Takuma Nakatsuka, Tatsuya Minami,[...]. J Hepatol 2015
278
50

Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia.
Roger A Fielding, Bruno Vellas, William J Evans, Shalender Bhasin, John E Morley, Anne B Newman, Gabor Abellan van Kan, Sandrine Andrieu, Juergen Bauer, Denis Breuille,[...]. J Am Med Dir Assoc 2011
50

Tumor location as an indicator of survival in T1 resectable pancreatic ductal adenocarcinoma: a propensity score-matched analysis.
Zibo Meng, Mingsi Cao, Yushun Zhang, Zhiqiang Liu, Shihong Wu, Heshui Wu. BMC Gastroenterol 2019
7
50

Protocol digest of randomized phase II study of modified FOLFIRINOX versus gemcitabine plus nab-paclitaxel combination therapy for locally advanced pancreatic cancer: Japan clinical oncology group study (JCOG1407).
Junki Mizusawa, Akira Fukutomi, Hiroshi Katayama, Hiroshi Ishii, Tatsuya Ioka, Takuji Okusaka, Hideki Ueno, Makoto Ueno, Masafumi Ikeda, Nobumasa Mizuno,[...]. Pancreatology 2018
11
50

Chemotherapy in elderly patients with pancreatic cancer: Efficacy, feasibility and future perspectives.
Marina Macchini, Marta Chiaravalli, Silvia Zanon, Umberto Peretti, Elena Mazza, Luca Gianni, Michele Reni. Cancer Treat Rev 2019
18
50

Influence of cachexia and sarcopenia on survival in pancreatic ductal adenocarcinoma: a systematic review.
I Ozola Zalite, R Zykus, M Francisco Gonzalez, F Saygili, A Pukitis, S Gaujoux, R M Charnley, V Lyadov. Pancreatology 2015
78
50

Sarcopenia is associated with reduced survival in patients with advanced hepatocellular carcinoma undergoing sorafenib treatment.
Giulio Antonelli, Elia Gigante, Massimo Iavarone, Paola Begini, Angelo Sangiovanni, Elsa Iannicelli, Piero Biondetti, Adriano M Pellicelli, Lucia Miglioresi, Paolo Marchetti,[...]. United European Gastroenterol J 2018
23
50

The Challenge by Multiple Environmental and Biological Factors Induce Inflammation in Aging: Their Role in the Promotion of Chronic Disease.
María Consuelo Bachmann, Sofía Bellalta, Roque Basoalto, Fernán Gómez-Valenzuela, Yorschua Jalil, Macarena Lépez, Anibal Matamoros, Rommy von Bernhardi. Front Immunol 2020
7
50

Carnitine induces autophagy and restores high-fat diet-induced mitochondrial dysfunction.
Jin Woo Choi, Jung Hun Ohn, Hye Seung Jung, Young Joo Park, Hak Chul Jang, Sung Soo Chung, Kyong Soo Park. Metabolism 2018
20
50

Relationship of carbohydrate antigen 19-9 and Lewis antigens in pancreatic cancer.
M A Tempero, E Uchida, H Takasaki, D A Burnett, Z Steplewski, P M Pour. Cancer Res 1987
256
50

International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017.
Shuji Isaji, Shugo Mizuno, John A Windsor, Claudio Bassi, Carlos Fernández-Del Castillo, Thilo Hackert, Aoi Hayasaki, Matthew H G Katz, Sun-Whe Kim, Masashi Kishiwada,[...]. Pancreatology 2018
180
50

Defining the molecular pathology of pancreatic body and tail adenocarcinoma.
S B Dreyer, N B Jamieson, R Upstill-Goddard, P J Bailey, C J McKay, A V Biankin, D K Chang. Br J Surg 2018
50
50

Prognostic Factors for Risk Stratification of Patients with Recurrent or Metastatic Pancreatic Adenocarcinoma Who Were Treated with Gemcitabine-Based Chemotherapy.
Inkeun Park, Seung Joon Choi, Young Saing Kim, Hee Kyung Ahn, Junshik Hong, Sun Jin Sym, Jinny Park, Eun Kyung Cho, Jae Hoon Lee, Yong Ju Shin,[...]. Cancer Res Treat 2016
21
50

Prognostic value of CA 19-9, CEA, CRP, LDH and bilirubin levels in locally advanced and metastatic pancreatic cancer: results from a multicenter, pooled analysis of patients receiving palliative chemotherapy.
Michael Haas, Volker Heinemann, Frank Kullmann, Rüdiger P Laubender, Christina Klose, Christiane J Bruns, Stefan Holdenrieder, Dominik P Modest, Christoph Schulz, Stefan Boeck. J Cancer Res Clin Oncol 2013
88
50

Diversity of Precursor Lesions For Pancreatic Cancer: The Genetics and Biology of Intraductal Papillary Mucinous Neoplasm.
Krushna C Patra, Nabeel Bardeesy, Yusuke Mizukami. Clin Transl Gastroenterol 2017
51
50

Sarcopenia in patients with colorectal cancer: A comprehensive review.
Omar Vergara-Fernandez, Mario Trejo-Avila, Noel Salgado-Nesme. World J Clin Cases 2020
10
50

Association of the location of pancreatic ductal adenocarcinoma (head, body, tail) with tumor stage, treatment, and survival: a population-based analysis.
Felice N van Erning, Tara M Mackay, Lydia G M van der Geest, B Groot Koerkamp, Hanneke W M van Laarhoven, Bert A Bonsing, Johanna W Wilmink, Hjalmar C van Santvoort, Judith de Vos-Geelen, Casper H J van Eijck,[...]. Acta Oncol 2018
28
50

Sarcopenia is a reliable prognostic factor in patients with advanced pancreatic cancer receiving FOLFIRINOX chemotherapy.
Yusuke Kurita, Noritoshi Kobayashi, Motohiko Tokuhisa, Ayumu Goto, Kensuke Kubota, Itaru Endo, Atsushi Nakajima, Yasushi Ichikawa. Pancreatology 2019
24
50

Altered exocrine function can drive adipose wasting in early pancreatic cancer.
Laura V Danai, Ana Babic, Michael H Rosenthal, Emily A Dennstedt, Alexander Muir, Evan C Lien, Jared R Mayers, Karen Tai, Allison N Lau, Paul Jones-Sali,[...]. Nature 2018
57
50

Markers of sarcopenia quantified by computed tomography predict adverse long-term outcome in patients with resected oesophageal or gastro-oesophageal junction cancer.
Dietmar Tamandl, Matthias Paireder, Reza Asari, Pascal A Baltzer, Sebastian F Schoppmann, Ahmed Ba-Ssalamah. Eur Radiol 2016
122
50

Efficacy of Docetaxel and Oxaliplatin Regimen as a Second-Line Therapy for Patients with Advanced Pancreatic Adenocarcinoma.
Amal Rayan, Ola N Abdel Fattah, Ahmed Soliman, Hosam A Hasan, Asmaa M Zahran. J Gastrointest Cancer 2019
2
50

Prognostic role of the neutrophil-to-lymphocyte ratio in pancreatic cancer: a meta-analysis.
Hao Cheng, Feiwu Long, Mukesh Jaiswar, Lie Yang, Cun Wang, Zongguang Zhou. Sci Rep 2015
57
50

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer.
Thierry Conroy, Françoise Desseigne, Marc Ychou, Olivier Bouché, Rosine Guimbaud, Yves Bécouarn, Antoine Adenis, Jean-Luc Raoul, Sophie Gourgou-Bourgade, Christelle de la Fouchardière,[...]. N Engl J Med 2011
50


A Preoperative Prognostic Scoring System to Predict Prognosis for Resectable Pancreatic Cancer: Who Will Benefit from Upfront Surgery?
Toru Nakamura, Toshimichi Asano, Keisuke Okamura, Takahiro Tsuchikawa, Soichi Murakami, Yo Kurashima, Yuma Ebihara, Takehiro Noji, Yoshitsugu Nakanishi, Kimitaka Tanaka,[...]. J Gastrointest Surg 2019
9
50

Pancreatic adenocarcinoma.
David P Ryan, Theodore S Hong, Nabeel Bardeesy. N Engl J Med 2014
50

Application of Weibull model for survival of patients with gastric cancer.
Hui P Zhu, Xin Xia, Chuan H Yu, Ahmed Adnan, Shun F Liu, Yu K Du. BMC Gastroenterol 2011
41
50

Pretreatment CA 19-9 level as a prognostic factor in patients with advanced pancreatic cancer treated with gemcitabine.
Everardo D Saad, Marcel C Machado, Dalia Wajsbrot, Roberto Abramoff, Paulo M Hoff, Jacques Tabacof, Artur Katz, Sergio D Simon, René C Gansl. Int J Gastrointest Cancer 2002
74
50

CEA and CA-19.9 serum tumor markers as prognostic factors in patients with locally advanced (unresectable) or metastatic pancreatic adenocarcinoma: a retrospective analysis.
N Tsavaris, C Kosmas, N Papadoniou, P Kopterides, K Tsigritis, A Dokou, J Sarantonis, H Skopelitis, M Tzivras, K Gennatas,[...]. J Chemother 2009
16
50

Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People.
Alfonso J Cruz-Jentoft, Jean Pierre Baeyens, Jürgen M Bauer, Yves Boirie, Tommy Cederholm, Francesco Landi, Finbarr C Martin, Jean-Pierre Michel, Yves Rolland, Stéphane M Schneider,[...]. Age Ageing 2010
50

Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis.
Arnoud J Templeton, Mairéad G McNamara, Boštjan Šeruga, Francisco E Vera-Badillo, Priya Aneja, Alberto Ocaña, Raya Leibowitz-Amit, Guru Sonpavde, Jennifer J Knox, Ben Tran,[...]. J Natl Cancer Inst 2014
50

Impact of Skeletal Muscle Mass, Muscle Quality, and Visceral Adiposity on Outcomes Following Resection of Intrahepatic Cholangiocarcinoma.
Shinya Okumura, Toshimi Kaido, Yuhei Hamaguchi, Atsushi Kobayashi, Hisaya Shirai, Yasuhiro Fujimoto, Taku Iida, Shintaro Yagi, Kojiro Taura, Etsuro Hatano,[...]. Ann Surg Oncol 2017
51
50

Power of computed-tomography-defined sarcopenia for prediction of morbidity after pancreaticoduodenectomy.
Nicolas Linder, Alexander Schaudinn, Katharina Langenhan, Felix Krenzien, Hans-Michael Hau, Christian Benzing, Georgi Atanasov, Moritz Schmelzle, Thomas Kahn, Harald Busse,[...]. BMC Med Imaging 2019
15
50

Evaluation of Modified Glasgow Prognostic Score for Pancreatic Cancer: A Retrospective Cohort Study.
Hiroshi Imaoka, Nobumasa Mizuno, Kazuo Hara, Susumu Hijioka, Masahiro Tajika, Tsutomu Tanaka, Makoto Ishihara, Tatsuji Yogi, Hideharu Tsutsumi, Toshihisa Fujiyoshi,[...]. Pancreas 2016
38
50

Evaluative frailty index for physical activity (EFIP): a reliable and valid instrument to measure changes in level of frailty.
Nienke M de Vries, J Bart Staal, Marcel G M Olde Rikkert, Maria W G Nijhuis-van der Sanden. Phys Ther 2013
24
50

Impact of the treatment of pancreatic exocrine insufficiency on survival of patients with unresectable pancreatic cancer: a retrospective analysis.
Juan Enrique Domínguez-Muñoz, Laura Nieto-Garcia, Javier López-Díaz, Jose Lariño-Noia, Ihab Abdulkader, Julio Iglesias-Garcia. BMC Cancer 2018
36
50

Frailty syndrome and skeletal muscle: results from the Invecchiare in Chianti study.
Matteo Cesari, Christiaan Leeuwenburgh, Fulvio Lauretani, Graziano Onder, Stefania Bandinelli, Cinzia Maraldi, Jack M Guralnik, Marco Pahor, Luigi Ferrucci. Am J Clin Nutr 2006
209
50

The Significance of the Prognostic Nutritional Index for All Stages of Pancreatic Cancer.
Sang Hoon Lee, Moon Jae Chung, Bun Kim, Hee Seung Lee, Hyun Jik Lee, Ja Yoon Heo, Yeong Jin Kim, Jeong Youp Park, Seungmin Bang, Seung Woo Park,[...]. Nutr Cancer 2017
29
50

Metastatic Pancreatic Cancer: ASCO Clinical Practice Guideline Update.
Davendra P S Sohal, Erin B Kennedy, Alok Khorana, Mehmet S Copur, Christopher H Crane, Ignacio Garrido-Laguna, Smitha Krishnamurthi, Cassadie Moravek, Eileen M O'Reilly, Philip A Philip,[...]. J Clin Oncol 2018
100
50

Utility of the modified frailty index in predicting toxicity and cancer outcomes for older adults with advanced pancreatic cancer receiving first-line palliative chemotherapy.
Rebekah Rittberg, Hanbo Zhang, Pascal Lambert, Robert Kudlovich, Christina A Kim, David E Dawe. J Geriatr Oncol 2021
1
100


Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography.
N Mitsiopoulos, R N Baumgartner, S B Heymsfield, W Lyons, D Gallagher, R Ross. J Appl Physiol (1985) 1998
846
50

Development and validation of a prognostic nomogram to predict survival in patients with advanced pancreatic cancer receiving second-line palliative chemotherapy.
Chih-Chung Hsu, Keng-Hao Liu, Pei-Hung Chang, Ping-Tsung Chen, Chia-Yen Hung, Shun-Wen Hsueh, Kun-Yun Yeh, Yen-Yang Chen, Chang-Hsien Lu, Yu-Shin Hung,[...]. J Gastroenterol Hepatol 2020
2
50

Platelet-to-lymphocyte ratio in advanced Cancer: Review and meta-analysis.
Bo Li, Pingting Zhou, Yujie Liu, Haifeng Wei, Xinghai Yang, Tianrui Chen, Jianru Xiao. Clin Chim Acta 2018
35
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.